Key Factor Study for Generic Long-Acting PLGA Microspheres Based on a Reverse Engineering of Vivitrol^®

The FDA (U.S. Food and Drug Administration) has approved only a negligible number of poly(lactide-co-glycolide) (PLGA)-based microsphere formulations, indicating the difficulty in developing a PLGA microsphere. A thorough understanding of microsphere formulations is essential to meet the challenge o...

Descrición completa

Detalles Bibliográficos

Principais autores:	Yabing Hua, Zengming Wang, Dan Wang, Xiaoming Lin, Boshi Liu, Hui Zhang, Jing Gao, Aiping Zheng
Formato:	Artigo
Idioma:	Inglês
Publicado:	MDPI AG 2021-02-01
Series:	Molecules
Assuntos:	PLGA microspheres reverse engineering Vivitrol<sup>®</sup> generic naltrexone-loaded microspheres critical process parameters
Acceso en liña:	https://www.mdpi.com/1420-3049/26/5/1247
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!